Marker Therapeutics Inc (MRKR)

[Phantom Lord]

November 10, 2021: Q3 2021 Update PR (HERE)
“Topline readout of Group 2 active disease anticipated in Q1 2022

March 17, 2022: YE 2021 Update PR (HERE)
“Topline readout of Group 2 active disease anticipated in Q2 2022”

May 13, 2022: Q1 2022 Update PR (HERE)
“Topline readout of Group 2 active disease is anticipated in Q2 2022”

August 11, 2022: Q2 2022 Update PR (HERE)
“We expect to provide a topline readout of active disease patients in Q3 2022”

I sure hope they don't miss their release date for a third time but they have not instilled a lot of confidence with this. Not only have they missed their stated release of data twice already they have not even acknowledged it. The least they can do is provide an explanation for the continued delay of the data. Delay could be good or bad but by not acknowledging it one way or the other they leave everyone to think the worst.

I still believe in the science as I have since the beginning but this is just poor business practice no matter how you look at it.